ECSP972071A - EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION - Google Patents
EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATIONInfo
- Publication number
- ECSP972071A ECSP972071A ECSP972071A ECSP972071A EC SP972071 A ECSP972071 A EC SP972071A EC SP972071 A ECSP972071 A EC SP972071A EC SP972071 A ECSP972071 A EC SP972071A
- Authority
- EC
- Ecuador
- Prior art keywords
- production
- formulation
- procedure
- dihydrate
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- -1 EPROSARTAN DIHYDRATE Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002080 C09CA02 - Eprosartan Substances 0.000 title 1
- 229960004563 eprosartan Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000008873 Angiotensin II receptor Human genes 0.000 abstract 1
- 108050000824 Angiotensin II receptor Proteins 0.000 abstract 1
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 abstract 1
- UAAKJEVCDBPTQS-UHFFFAOYSA-N methanesulfonic acid;dihydrate Chemical compound O.O.CS(O)(=O)=O UAAKJEVCDBPTQS-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención se refiere a dihidrato de monometanosulfonato de ácido (E) -alfa- [2-n-butil -1- [(4-carboxifenil)meti] -1H- imidazol - 5 - iL] metilen -2- tiofenopropiónico, un procedimiento para su producción, composiciones que contienen el compuesto y métodos de uso del compuesto para bloquear los receptores de la angiotensina II y para tratar la hipertención la insuficiencia cardíaca congestiva y la insuficiencia renal.This invention relates to (E) -alpha- [2-n-butyl -1- [(4-carboxyphenyl) meth] -1H-imidazole-5-iL] methylene-2-thiophene propropionic monomethanesulfonate dihydrate, a method for their production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and kidney failure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972071 ECSP972071A (en) | 1997-04-27 | 1997-04-27 | EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972071 ECSP972071A (en) | 1997-04-27 | 1997-04-27 | EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972071A true ECSP972071A (en) | 1998-04-17 |
Family
ID=42042904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972071 ECSP972071A (en) | 1997-04-27 | 1997-04-27 | EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972071A (en) |
-
1997
- 1997-04-27 EC ECSP972071 patent/ECSP972071A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR006439A1 (en) | EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION | |
| PT1305286E (en) | CYCLOPENTANOINDOLES COMPOSITIONS CONTAINING THE REFERRED COMPOUNDS AND METHODS OF TREATMENT | |
| ES2185617T3 (en) | PHARMACEUTICAL COMPOSITIONS OF AN IMIDAZOLIL-ALKENOIC ACID SALT AND ITS USE AS ANTAGONISTS OF ANGIOTENSIN II. | |
| TR200000782T2 (en) | Resorcinol derivatives. | |
| HN1998000157A (en) | PROSTAGLANDIN AGONISTS | |
| ATE291890T1 (en) | ANNULUS REPAIR SYSTEM | |
| JO2481B1 (en) | Fluoro substituted cycloalkanoindoles, compositions containing such compou- nds and methods of treatment. | |
| ES2178298T3 (en) | ANTI-INFLAMMATORY COMPOUNDS. | |
| EA199700116A1 (en) | TRICYCLIC BENZEZEPINS AS VAZOPRESSIN ANTAGONISTS, A METHOD OF THEIR RECEIVING, A PHARMOCOMPOSITION ON THEIR BASIS AND A METHOD OF TREATMENT | |
| YU173791A (en) | INDOL AND BENZIMIDAZOLE-SUBSTITUTED IMIDAZOLE AND BENZIMIDAZOLE DERIVATIVES | |
| AR037065A1 (en) | A PHARMACEUTICAL COMPOSITION BASED ON 5HT3 AND 5HT4 RECEIVER BLOCKERS, PROTON PUMP INHIBITORS AND H2 RECEIVER ANTAGONISTS, USED TO TREAT GASTROINTESTINAL DISORDERS | |
| DK0492105T3 (en) | Angiotensin II receptor blocks for the treatment of cardiac hypertrophy | |
| TW200508226A (en) | Compositions, combinations, and methods for treating cardiovascular conditions and other associated conditions | |
| DK0912537T3 (en) | Process for the preparation of phenylheterocyclic compounds useful as cox-2 inhibitors | |
| BR0007864A (en) | Compound, and, use of a compound | |
| ES2182334T3 (en) | EPROSARTAN MONOHIDRATE. | |
| ECSP972071A (en) | EPROSARTAN DIHYDRATE AND A PROCEDURE FOR ITS PRODUCTION AND FORMULATION | |
| WO2001030330A3 (en) | Method to treat pain utilizing benzimidazole nmda/nr2b antagonists | |
| CA2310028A1 (en) | High drug load immediate and modified release oral dosage formulations and processes for their manufacture | |
| GT199900037A (en) | NEW HERBICIDE COMPOSITIONS. | |
| SE0001373D0 (en) | NPY Y1 receptor agonists and antagonists | |
| ATE267005T1 (en) | STABLE GALENIC PREPARATIONS COMPRISING A BENZIMIDAZOLE AND METHOD FOR THE PRODUCTION THEREOF | |
| AR015930A1 (en) | COMPUTER NEUTRALIZATION OF LOADS WITH EPROSARTAN ARGINYL, PROCEDURE FOR PRODUCTION AND FORMULATION, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PROCEDURE TO PREPARE SUCH COMPOSITION. | |
| UY26594A1 (en) | PROCESS FOR THE SIMPLE PREPARATION OF (3-CHLORINE-4FLUOROPHENYL) - (7- (3-MORPHOLINE-4-ILOPROPOXI) -6-NITROQUINAZOLNA-4YL) -AMINE OR (3-CHLORINE-4-FLUOROPHENYL) - (7- ( 3-MORPHOLINE-4-IL-PROPOXI) -6-AMINOQUINAZOLINE-4-ILO) -AMINE. | |
| AR020142A1 (en) | A COMPOUND DERIVED FROM ARGININE, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO ANALOGONIZE A RECEIVER FOR C3A |